Ceramide Testing for Major Adverse Cardiovascular Events
2025 American Family Physician diagnostic review of the MI-Heart Ceramides test: a 0-12 ceramide risk score (three ceramides and three ratios, quartile-scored) that stratifies 1-5-year risk of major adverse cardiovascular events in adults; not FDA-approved.
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
American Family Physician
Feb 2025
Structured Methods
- Study Design
- Review
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (2025). Ceramide Testing for Major Adverse Cardiovascular Events. American Family Physician.
Source
Publisher
Journal
American Family Physician
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
